Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6696328
[patent_doc_number] => 20030108522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Method for using Smad for gene therapy of solid malignant tumors'
[patent_app_type] => new
[patent_app_number] => 10/231921
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6777
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108522.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231921 | Method for using Smad for gene therapy of solid malignant tumors | Aug 29, 2002 | Abandoned |
Array
(
[id] => 6779191
[patent_doc_number] => 20030050273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Compositions and methods for treating neurodegenerative diseases'
[patent_app_type] => new
[patent_app_number] => 10/230875
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18043
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10230875
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/230875 | Compositions and methods for treating neurodegenerative diseases | Aug 27, 2002 | Abandoned |
Array
(
[id] => 6689896
[patent_doc_number] => 20030033622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Transgenic insect'
[patent_app_type] => new
[patent_app_number] => 10/148772
[patent_app_country] => US
[patent_app_date] => 2002-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3402
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20030033622.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148772
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148772 | Transgenic insect | Aug 26, 2002 | Abandoned |
Array
(
[id] => 6839184
[patent_doc_number] => 20030036524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'Method of sensitising endothelial cells to prodrugs'
[patent_app_type] => new
[patent_app_number] => 10/220151
[patent_app_country] => US
[patent_app_date] => 2002-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4466
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20030036524.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220151
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220151 | Method of sensitising endothelial cells to prodrugs | Aug 26, 2002 | Abandoned |
Array
(
[id] => 6792523
[patent_doc_number] => 20030087867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Gene therapy for enhancing and/or inducing angiogenesis'
[patent_app_type] => new
[patent_app_number] => 10/224249
[patent_app_country] => US
[patent_app_date] => 2002-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7492
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087867.pdf
[firstpage_image] =>[orig_patent_app_number] => 10224249
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/224249 | Gene therapy for enhancing and/or inducing angiogenesis | Aug 18, 2002 | Abandoned |
Array
(
[id] => 6745676
[patent_doc_number] => 20030022859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Method for increasing the gene expression of transfected genes'
[patent_app_type] => new
[patent_app_number] => 10/203924
[patent_app_country] => US
[patent_app_date] => 2002-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2368
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022859.pdf
[firstpage_image] =>[orig_patent_app_number] => 10203924
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/203924 | Method for increasing the gene expression of transfected genes | Aug 15, 2002 | Abandoned |
Array
(
[id] => 836710
[patent_doc_number] => 07393524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-01
[patent_title] => 'Baculovirus vectors comprising a capsid polypeptide fused to a GNRH polypeptide'
[patent_app_type] => utility
[patent_app_number] => 10/486698
[patent_app_country] => US
[patent_app_date] => 2002-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4982
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/393/07393524.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486698
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486698 | Baculovirus vectors comprising a capsid polypeptide fused to a GNRH polypeptide | Aug 14, 2002 | Issued |
Array
(
[id] => 6869517
[patent_doc_number] => 20030082206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Method of preserving infectious recombinant viruses, aqueous viral suspension, and use as medicament'
[patent_app_type] => new
[patent_app_number] => 10/218564
[patent_app_country] => US
[patent_app_date] => 2002-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4136
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082206.pdf
[firstpage_image] =>[orig_patent_app_number] => 10218564
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/218564 | Method of preserving infectious recombinant viruses, aqueous viral suspension, and use as medicament | Aug 14, 2002 | Abandoned |
Array
(
[id] => 6654099
[patent_doc_number] => 20030077261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Modulation of angiogenesis by A-beta peptides'
[patent_app_type] => new
[patent_app_number] => 10/217584
[patent_app_country] => US
[patent_app_date] => 2002-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20525
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077261.pdf
[firstpage_image] =>[orig_patent_app_number] => 10217584
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/217584 | Inhibition of angiogenesis by A-β peptides | Aug 11, 2002 | Issued |
10/089710 | Autologous marrow stem cell (msc) transplantation for myocardial regeneration | Jul 28, 2002 | Abandoned |
Array
(
[id] => 7997579
[patent_doc_number] => 08080637
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-12-20
[patent_title] => 'Therapeutic method of treating brain trauma in rodents with VCP'
[patent_app_type] => utility
[patent_app_number] => 10/199979
[patent_app_country] => US
[patent_app_date] => 2002-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 5628
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/080/08080637.pdf
[firstpage_image] =>[orig_patent_app_number] => 10199979
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/199979 | Therapeutic method of treating brain trauma in rodents with VCP | Jul 18, 2002 | Issued |
Array
(
[id] => 7398487
[patent_doc_number] => 20040018622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Spliceosome mediated RNA trans-splicing for correction of skin disorders '
[patent_app_type] => new
[patent_app_number] => 10/198447
[patent_app_country] => US
[patent_app_date] => 2002-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16845
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20040018622.pdf
[firstpage_image] =>[orig_patent_app_number] => 10198447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/198447 | Spliceosome mediated RNA trans-splicing for correction of skin disorders | Jul 16, 2002 | Abandoned |
10/019800 | Dna constructs based on the elf4a gene promoter | Jul 16, 2002 | Abandoned |
Array
(
[id] => 6779189
[patent_doc_number] => 20030050271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Gene transfer into the kidney'
[patent_app_type] => new
[patent_app_number] => 10/192754
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11103
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050271.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192754
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192754 | Gene transfer into the kidney | Jul 9, 2002 | Abandoned |
Array
(
[id] => 6744585
[patent_doc_number] => 20030021768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Viral mutants that selectively replicate in targeted human cancer cells'
[patent_app_type] => new
[patent_app_number] => 10/191922
[patent_app_country] => US
[patent_app_date] => 2002-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7709
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20030021768.pdf
[firstpage_image] =>[orig_patent_app_number] => 10191922
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/191922 | Viral mutants that selectively replicate in targeted human cancer cells | Jul 8, 2002 | Abandoned |
Array
(
[id] => 6871776
[patent_doc_number] => 20030084466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'System and method for controlling male fertility'
[patent_app_type] => new
[patent_app_number] => 10/192867
[patent_app_country] => US
[patent_app_date] => 2002-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19543
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20030084466.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192867 | System and method for controlling male fertility | Jul 7, 2002 | Abandoned |
Array
(
[id] => 6870609
[patent_doc_number] => 20030083299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Non-invasive delivery of polypeptides through the blood-brain barrier'
[patent_app_type] => new
[patent_app_number] => 10/188184
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 48492
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10188184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/188184 | Non-invasive delivery of polypeptides through the blood-brain barrier | Jul 1, 2002 | Abandoned |
Array
(
[id] => 6825583
[patent_doc_number] => 20030236205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Hybridization signal amplification method (HSAM) nanostructures for diagnostic and therapeutic uses'
[patent_app_type] => new
[patent_app_number] => 10/176515
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6818
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20030236205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10176515
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/176515 | Hybridization signal amplification method (HSAM) nanostructures for diagnostic and therapeutic uses | Jun 20, 2002 | Abandoned |
Array
(
[id] => 7398495
[patent_doc_number] => 20040023218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Purified nucleic acid molecule for the expression of a lysosomal enzyme and use thereof for preventing or treating lysosomal storage diseases'
[patent_app_type] => new
[patent_app_number] => 10/176066
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8374
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023218.pdf
[firstpage_image] =>[orig_patent_app_number] => 10176066
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/176066 | Vector for expressing α-L-iduronidase and method of treating MPS I by stereotactic injection into the brain of a mammal | Jun 20, 2002 | Issued |
Array
(
[id] => 6688459
[patent_doc_number] => 20030032184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Liver engrafting cells, assays, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/177178
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 13190
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032184.pdf
[firstpage_image] =>[orig_patent_app_number] => 10177178
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/177178 | Liver engrafting cells, assays, and uses thereof | Jun 20, 2002 | Issued |